Search research articles
Contact Us
Filters
Showing results (21-30 of 189) with videos related to
Page
of 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?
Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 12, 2005
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy
C Warren Olanow, Joseph Jankovic
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 2014
Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research awardees
C Warren Olanow, Jose Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2015
Advances in clinical trials for movement disorders
Karl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 28, 2017
Levodopa: A new look at an old friend
C Warren Olanow, Fabrizio Stocchi
Neurology
|
May 24, 2006
The pathogenesis of cell death in Parkinson's disease
Peter Jenner, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 1, 2011
Parkinson's disease, proteins, and prions: milestones
C Warren Olanow, K McNaught
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2014
"Psychogenic movement disorders": they are what they are
Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 4, 2012
Stem cells for Parkinson's disease: advancing science but protecting patients
C Warren Olanow, Ole Isacson
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2010
Defining disease-modifying therapies for PD--a road map for moving forward
C Warren Olanow, Karl Kieburtz
Page
of 19
Search research articles
Search
Showing results (21-30 of 189) with videos related to
Sort By:
Page
of 19
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?
Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 12, 2005
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy
C Warren Olanow, Joseph Jankovic
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 2014
Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research awardees
C Warren Olanow, Jose Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2015
Advances in clinical trials for movement disorders
Karl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 28, 2017
Levodopa: A new look at an old friend
C Warren Olanow, Fabrizio Stocchi
Neurology
|
May 24, 2006
The pathogenesis of cell death in Parkinson's disease
Peter Jenner, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 1, 2011
Parkinson's disease, proteins, and prions: milestones
C Warren Olanow, K McNaught
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2014
"Psychogenic movement disorders": they are what they are
Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 4, 2012
Stem cells for Parkinson's disease: advancing science but protecting patients
C Warren Olanow, Ole Isacson
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2010
Defining disease-modifying therapies for PD--a road map for moving forward
C Warren Olanow, Karl Kieburtz
Page
of 19